BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17161356)

  • 1. Reccurence of Kaposi's sarcoma after increased exposure to sirolimus.
    Boratyńska M; Zmonarski SC; Klinger M
    Int Immunopharmacol; 2006 Dec; 6(13-14):2018-22. PubMed ID: 17161356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regression of Kaposi's sarcoma in renal graft recipients after conversion to sirolimus treatment.
    Zmonarski SC; Boratyńska M; Rabczyński J; Kazimierczak K; Klinger M
    Transplant Proc; 2005 Mar; 37(2):964-6. PubMed ID: 15848592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of Kaposi's sarcoma under sirolimus-based immunosuppression and successful treatment with imiquimod.
    Babel N; Eibl N; Ulrich C; Bold G; Sefrin A; Hammer MH; Rosenberger C; Reinke P
    Transpl Infect Dis; 2008 Feb; 10(1):59-62. PubMed ID: 17428275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regression of post-transplant Kaposi's sarcoma using sirolimus.
    Kolhe N; Mamode N; Van der Walt J; Pattison J
    Int J Clin Pract; 2006 Nov; 60(11):1509-12. PubMed ID: 16787440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of conversion to sirolimus in posttransplantation Kaposi's sarcoma.
    Gutiérrez-Dalmau A; Sánchez-Fructuoso A; Sanz-Guajardo A; Mazuecos A; Franco A; Rial MC; Iranzo P; Torregrosa JV; Oppenheimer F; Campistol JM
    Transplant Proc; 2005 Nov; 37(9):3836-8. PubMed ID: 16386556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
    Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
    Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus for Kaposi's sarcoma in renal-transplant recipients.
    Stallone G; Schena A; Infante B; Di Paolo S; Loverre A; Maggio G; Ranieri E; Gesualdo L; Schena FP; Grandaliano G
    N Engl J Med; 2005 Mar; 352(13):1317-23. PubMed ID: 15800227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel immunosuppressive agent, sirolimus, in the treatment of Kaposi's sarcoma in a renal transplant recipient.
    Yilmaz R; Akoglu H; Kirkpantur A; Kilickap S; Arici M; Altun B; Aki T; Erdem Y; Yasavul U; Turgan C
    Ren Fail; 2007; 29(1):103-5. PubMed ID: 17365918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of post-renal transplant gastric and pulmonary Kaposi's sarcoma with conversion to rapamycin treatment.
    Charfi S; Krichen-Makni S; Yaich S; Makni H; Khabir A; Amouri A; Charfeddine K; Hachicha J; Sellami-Boudawara T
    Saudi J Kidney Dis Transpl; 2007 Nov; 18(4):617-20. PubMed ID: 17951954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Localized Kaposi's sarcoma in a patient with pemphigus vulgaris.
    Avalos-Peralta P; Herrera A; Ríos-Martín JJ; Pérez-Bernal AM; Moreno-Ramírez D; Camacho F
    J Eur Acad Dermatol Venereol; 2006 Jan; 20(1):79-83. PubMed ID: 16405614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecularly targeted therapy for Kaposi's sarcoma in a kidney transplant patient: case report, "what worked and what did not".
    Volkow P; Zinser JW; Correa-Rotter R
    BMC Nephrol; 2007 Mar; 8():6. PubMed ID: 17386117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conversion to sirolimus: a successful treatment for posttransplantation Kaposi's sarcoma.
    Campistol JM; Gutierrez-Dalmau A; Torregrosa JV
    Transplantation; 2004 Mar; 77(5):760-2. PubMed ID: 15021843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus and mycophenolate mofetil after liver transplantation.
    Kniepeiss D; Iberer F; Grasser B; Schaffellner S; Tscheliessnigg KH
    Transpl Int; 2003 Jul; 16(7):504-9. PubMed ID: 12687325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sirolimus for the treatment of Kaposi sarcoma after renal transplantation: a series of 10 cases.
    Yaich S; Charfeddine K; Zaghdane S; El Aoud N; Jarraya F; Kharrat M; Hachicha J
    Transplant Proc; 2012 Nov; 44(9):2824-6. PubMed ID: 23146533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus for Kaposi's sarcoma.
    Wasywich CA; Croxson MC; van Doornum GJ; Coverdale HA; Ruygrok PN
    J Heart Lung Transplant; 2006 Jun; 25(6):726-9. PubMed ID: 16730579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kaposi's sarcoma in renal transplant recipients.
    Zmonarski SC; Boratyńska M; Puziewicz-Zmonarska A; Kazimierczak K; Klinger M
    Ann Transplant; 2005; 10(2):59-65. PubMed ID: 16218035
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
    Campistol JM; Schena FP
    Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion to everolimus in a patient with arterial hypertension and recurrent cutaneous neoplasia--a case report.
    Pascual J; Fernández AM; Marcén R; Ortuño J
    Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii38-41. PubMed ID: 16815857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.